Cannabis-Induced Munchies Work Through the Brain's Orexin System by Triggering More Frequent Meals | Research

The takeaway

Cannabinoid-induced overeating in rats was driven by eating more frequently (not larger meals) and required the orexin-1 receptor in the brain, revealing a specific neural mechanism behind the "munchies."

Cannabis users curious about why it increases appetite and researchers studying cannabinoid-appetite interactions.

Blocking the orexin-1 receptor completely eliminated cannabinoid-induced hyperphagia

What the researchers found

Orally consumed cannabinoid edibles caused overeating by increasing meal frequency, not meal size. This hyperphagic effect required orexin-1 (OX1) receptor signaling. Blocking the OX1 receptor eliminated both the increased eating and the temporary burst of activity following cannabinoid consumption. Both cannabinoids and the OX1 antagonist independently reduced energy expenditure hours after administration.

Why it matters

The "munchies" is one of the most recognizable effects of cannabis, but the neural mechanism has been unclear. Identifying the orexin pathway as essential opens possibilities for managing unwanted appetite stimulation while preserving other therapeutic effects of cannabinoids.

The numbers in context

Cannabinoid edibles produced acute hyperphagia via increased meal number (not size). OX1 antagonist completely blocked cannabinoid-induced hyperphagia. Both cannabinoids and OX1 antagonist reduced energy expenditure several hours post-administration. Cannabinoid edibles also caused a transient increase in locomotor activity that was blocked by OX1 antagonism.

How the study worked

Male rats received cannabinoid receptor agonist (CP55940) via gelatin-based edibles. OX1 receptor involvement was tested by co-administering the antagonist SB334867. Metabolic monitoring cages captured food intake, locomotor activity, and metabolic variables simultaneously.

What this study cannot tell us

Male rats only. One cannabinoid agonist tested (CP55940), which is synthetic and more potent than THC. Oral gelatin edible delivery is novel but may not perfectly model human edible consumption. Short-term acute study.

How to read the evidence

Preliminary: single animal study using one synthetic cannabinoid in male rats only, though well-designed with metabolic cage monitoring.

When this study was published

2025 study.

The bigger picture

For patients using medical cannabis who struggle with unwanted appetite stimulation or weight gain, this research suggests the orexin system could be a target for selectively managing these side effects without eliminating other benefits.

Questions still open

Would blocking orexin-1 receptors prevent cannabis-related weight gain in humans? Does THC use the same orexin pathway as the synthetic agonist? Could orexin-targeted drugs complement medical cannabis by preventing unwanted appetite changes?

Common questions

Do the munchies come from eating bigger meals or more meals?

More meals. This study found cannabinoids increased meal frequency without changing meal size, suggesting they lower the threshold for initiating eating rather than making you eat more once you start.

Could this lead to a drug that blocks the munchies?

Potentially. Blocking the orexin-1 receptor eliminated cannabinoid-induced overeating in rats, suggesting this pathway could be targeted to prevent unwanted appetite stimulation from cannabis.

Read the original research

Cannabinoid-Induced Hyperphagia is Mediated by Increased Meal Frequency and the Orexin-1 Receptor in Male Rats.

Pharmacology research & perspectives, 13(5), e70171

View on PubMed ↗Publisher’s paper ↗

Citation

Lord, Magen N; Madu, Grace C; Loera-Lopez, Ana L; Aaron, Alexander P; Lin, Jessica; Noble, Emily E. (2025). Cannabinoid-Induced Hyperphagia is Mediated by Increased Meal Frequency and the Orexin-1 Receptor in Male Rats.. Pharmacology research & perspectives, 13(5), e70171. https://doi.org/10.1002/prp2.70171